These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29983670)

  • 41. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of CD44 and Cancer Stem Cells.
    Wang L; Zuo X; Xie K; Wei D
    Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages.
    Camp RL; Kraus TA; Puré E
    J Cell Biol; 1991 Dec; 115(5):1283-92. PubMed ID: 1955476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD44 cell adhesion molecules.
    Goodison S; Urquidi V; Tarin D
    Mol Pathol; 1999 Aug; 52(4):189-96. PubMed ID: 10694938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer.
    Mereiter S; Martins ÁM; Gomes C; Balmaña M; Macedo JA; Polom K; Roviello F; Magalhães A; Reis CA
    FEBS Lett; 2019 Jul; 593(13):1675-1689. PubMed ID: 31077346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
    Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
    Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Motility of colon cancer cells: modulation by CD44 isoform expression.
    Wong K; Rubenthiran U; Jothy S
    Exp Mol Pathol; 2003 Oct; 75(2):124-30. PubMed ID: 14516773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD44 in hematological neoplasias.
    Hertweck MK; Erdfelder F; Kreuzer KA
    Ann Hematol; 2011 May; 90(5):493-508. PubMed ID: 21258793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
    Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
    J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cell marker glycosylation: Nature, function and significance.
    Mallard BW; Tiralongo J
    Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells.
    Fernandes E; Freitas R; Ferreira D; Soares J; Azevedo R; Gaiteiro C; Peixoto A; Oliveira S; Cotton S; Relvas-Santos M; Afonso LP; Palmeira C; Oliveira MJ; Ferreira R; Silva AMN; Lara Santos L; Ferreira JA
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32252346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.
    Brown TA; Bouchard T; St John T; Wayner E; Carter WG
    J Cell Biol; 1991 Apr; 113(1):207-21. PubMed ID: 2007624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-throughput lectin magnetic bead array-coupled tandem mass spectrometry for glycoprotein biomarker discovery.
    Choi E; Loo D; Dennis JW; O'Leary CA; Hill MM
    Electrophoresis; 2011 Dec; 32(24):3564-75. PubMed ID: 22180208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.
    Thapa R; Wilson GD
    Stem Cells Int; 2016; 2016():2087204. PubMed ID: 27200096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.